Locally Advanced Stage IV Squamous Cell Carcinoma of the Head and Neck: Impact of Pre-Radiotherapy Hemoglobin Level and Interruptions During Radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 4, 2008, Pages 1108-1114

  Rades, Dirk ^a,b   Stoehr, Monika ^a   Kazic, Nadja ^c   Hakim, Samer G ^a   Walz, Annette ^a   Schild, Steven E ^d   Dunst, Juergen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c University in Sarajevo   (Bosnia and Herzegovina)

^d MAYO CLINIC   (United States)

Author keywords

prognostic factors; radiochemotherapy; Stage IV head and neck cancer; treatment outcome

Indexed keywords

BIOLOGICAL ORGANS; CHEMOTHERAPY; HEMOGLOBIN; PATIENT MONITORING; RADIOTHERAPY;

METASTASES-FREE SURVIVAL (MFS); PROGNOSTIC FACTORS; RADIOCHEMOTHERAPY; STAGE IV HEAD AND NECK CANCER;

ONCOLOGY;

CISPLATIN; FLUOROURACIL; HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; SEX RATIO; SQUAMOUS CELL CARCINOMA;

ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HEMOGLOBIN A; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 39749116414     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.07.2380     Document Type: Article

References (38)

1. Adelstein D.J., Li Y., Adams G.L., et al. An intergroup Phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21 (2003) 92-98
2. Vokes E.E., Weichselbaum R.R., Lipman S.M., et al. Head and neck cancer. N Engl J Med 328 (1993) 184-194
3. McKenna W.G., and Emami B. Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck cancer. Cancer 77 (1996) 1905-1911
4. Al-Sarraf M. Treatment of locally advanced head and neck cancer: Historical and critical review. Cancer Control 9 (2002) 387-399
5. Denis F., Garaud P., Bardet E., et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22 (2004) 69-76
6. Calais G., Alfonsi M., Bardet E., et al. Randomized trial of radiation therapy vs. concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 91 (1998) 2081-2086
7. Wendt T.G., Grabenbauer G.G., Roedel C.M., et al. Simultaneous radiochemotherapy vs. radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 16 (1998) 1318-1324
8. Brizel D.M., Albers M.E., Fisher S.R., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
9. Jeremic B., Shibamoto Y., Milicic B., et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial. J Clin Oncol 18 (2000) 1458-1464
10. Staar S., Rudat V., Stuetzer H., et al. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 1161-1171
11. Pignon J.P., Bourhis J., Domenge C., et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. Lancet 355 (2000) 949-955
12. Forastiere A.A., Goepfert H., Maor M., et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 348 (2003) 2091-2098
13. Arriagada R., Eschwege F., Cachin Y., et al. The value of combining radiotherapy with surgery in the treatment of hypopharyngeal and laryngeal cancers. Cancer 51 (1983) 1819-1825
14. Bartelink H., Breur K., Hart G., et al. The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer 52 (1983) 1008-1013
15. Nisi K.W., Foote R.L., Bonner J.A., et al. Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: Improved loco-regional disease control compared with surgery alone. Int J Radiat Oncol Biol Phys 41 (1998) 371-377
16. Regine W.F., Valentino J., Sloan D.A., et al. Postoperative radiation therapy for primary vs. recurrent squamous cell carcinoma of the head and neck: Results of a comparative analysis. Head Neck 21 (1999) 554-559
17. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
18. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
19. Bernier J., Cooper J.S., Pajak T.F., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27 (2005) 843-850
20. Marcial V.A., Pajak T.F., Mohiuddin M., et al. Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17. Cancer 66 (1990) 1861-1868
21. Al-Sarraf M., Pajak T.F., Byhardt R.W., et al. Postoperative radiotherapy with concurrent cisplatin appears to improve locoregional control of advanced, resectable head and neck cancers: RTOG 88-24. Int J Radiat Oncol Biol Phys 37 (1997) 777-782
22. Kaplan E.L., and Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
23. Cerezo L., Millan I., Torre A., et al. Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer 69 (1992) 1224-1234
24. Leemans C.R., Tiwari R., Nauta J.J., et al. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71 (1993) 452-456
25. Leibel S.A., Scott C.B., Mohiuddin M., et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: Results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 21 (1991) 549-556
26. Overgaard J., Hansen H.S., Overgaard M., et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 46 (1998) 135-146
27. Rades D., Schild S.E., Bahrehmand R., et al. Prognostic factors in the non-surgical treatment of esophageal cancer with radiotherapy or radiochemotherapy: The importance of pre-treatment hemoglobin levels. Cancer 103 (2005) 1740-1746
28. Langendijk H., de Jong J., Wanders R., et al. The importance of pre-treatment hemoglobin level in inoperable non-small cell lung carcinoma treated with radical radiotherapy. Radiother Oncol 67 (2003) 321-325
29. Vaupel P., Thews O., Mayer A., et al. Oxygenation status of gynecologic tumors: What is the optimal hemoglobin level?. Strahlenther Onkol 178 (2002) 727-731
30. Becker A., Stadler P., Lavay R.S., et al. Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 46 (2000) 459-466
31. Barton M.B., Keane T.J., Gadall T., et al. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 23 (1992) 137-143
32. Robertson C., Robertson A.G., Hendry J.H., et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 40 (1998) 319-329
33. Kwong D.L., Sham J.S., Chua D.T., et al. The effect of interruptions and prolonged treatment time in radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 39 (1997) 703-710
34. Suwinski R., Sowa A., Rutkowski T., et al. Time factor in postoperative radiotherapy: A multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 56 (2003) 399-412
35. Coles C.E., Burgess L., and Tan T. An audit of delays before and during radical radiotherapy for cervical cancer-effect on tumour cure probability. Clin Oncol 15 (2003) 47-54
36. Videtic G.M.M., Fung T., Tomiak A.T., et al. Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control. Lung Cancer 33 (2001) 249-258
37. Weber D.C., Kurtz J.M., and Allal A.S. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 675-680
38. Bese N.S., Sut P.A., and Ober A. The effect of treatment interruptions in the postoperative irradiation of breast cancer. Oncology 69 (2005) 214-223